Literature DB >> 15815006

Sequencing and resolution of amplified herpes simplex virus DNA with intermediate melting curves as genotype 1 or 2 by LightCycler PCR assay.

Nicolas C Issa1, Mark J Espy, James R Uhl, Thomas F Smith.   

Abstract

DNA from 101 specimens containing herpes simplex virus (HSV) produced atypical intermediate melting curves compared with those expected for HSV type 1 or HSV type 2 subsequent to real-time PCR. Nucleic acid sequence analysis of amplified target DNA revealed 1- or 3-bp polymorphisms in the probe region which allowed designation of these viruses as HSV genotype 1 or HSV genotype 2. These two subpopulations of HSV were also identified as HSV genotype 1 or HSV genotype 2 using another commercially available PCR method. Amplified HSV target DNA producing intermediate melting curves could be designated as HSV genotype 1 or HSV genotype 2 without performing sequencing or another PCR method with 96/101 (95%) specimens by adding known intermediate HSV DNA characteristic for the two subpopulations as controls.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15815006      PMCID: PMC1081363          DOI: 10.1128/JCM.43.4.1843-1845.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Comparison of Light-Cycler PCR, enzyme immunoassay, and tissue culture for detection of herpes simplex virus.

Authors:  M Koenig; K S Reynolds; W Aldous; M Hickman
Journal:  Diagn Microbiol Infect Dis       Date:  2001-07       Impact factor: 2.803

3.  Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR.

Authors:  M J Espy; J R Uhl; P S Mitchell; J N Thorvilson; K A Svien; A D Wold; T F Smith
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Failure to genotype herpes simplex virus by real-time PCR assay and melting curve analysis due to sequence variation within probe binding sites.

Authors:  Trevor P Anderson; Anja M Werno; Kirsten A Beynon; David R Murdoch
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Authors:  A Wald; J Zeh; S Selke; T Warren; A J Ryncarz; R Ashley; J N Krieger; L Corey
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region.

Authors:  G Sucato; A Wald; E Wakabayashi; J Vieira; L Corey
Journal:  J Infect Dis       Date:  1998-04       Impact factor: 5.226

7.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture.

Authors:  Julie Burrows; Andreas Nitsche; Belinda Bayly; Elise Walker; Geoff Higgins; TuckWeng Kok
Journal:  BMC Microbiol       Date:  2002-06-09       Impact factor: 3.605

  8 in total
  11 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Herpes simplex virus type 2 displays atypical melting-temperature profiles at low viral titers.

Authors:  Jason J LeBlanc; Sarah Campbell; Janice Pettipas; Todd F Hatchette; Ross J Davidson
Journal:  J Clin Microbiol       Date:  2008-06-04       Impact factor: 5.948

3.  Characterization of a novel melt curve by use of the Roche LightCycler HSV 1/2 analyte-specific reagent real-time PCR assay: frequencies of this novel (low) melt curve and commonly encountered (intermediate) melt curves.

Authors:  Bobby L Boyanton; Amro Almradi; Mark J Espy; Anne E Prada; John P Gibson; Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

4.  Simultaneous detection of herpes simplex virus 1 and 2 in the cerebrospinal fluid of a patient with seizures and encephalitis.

Authors:  Neil W Anderson; William Sistrunk; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2014-10-29       Impact factor: 5.948

5.  Rapid and direct detection of herpes simplex virus in cerebrospinal fluid by use of a commercial real-time PCR assay.

Authors:  Matthew J Binnicker; Mark J Espy; Cole L Irish
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

Review 6.  Diagnostics for herpes simplex virus: is PCR the new gold standard?

Authors:  Lara B Strick; Anna Wald
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

8.  Comparison of different polymerase chain reaction methods for detection of herpes simplex virus types 1 and 2 encephalitis.

Authors:  I Altuglu; A Zeytinoglu; H Sirin; N Yuceyar; S Erensoy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 5.103

Review 9.  Diagnostic Molecular Microbiology: A 2018 Snapshot.

Authors:  Marilynn Ransom Fairfax; Martin H Bluth; Hossein Salimnia
Journal:  Clin Lab Med       Date:  2018-06       Impact factor: 1.935

Review 10.  Diagnostic molecular microbiology: a 2013 snapshot.

Authors:  Marilynn Ransom Fairfax; Hossein Salimnia
Journal:  Clin Lab Med       Date:  2013-12       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.